Publication:
Lymphocyte subsets and specific T-cell immune response in thalassemia

dc.contributor.authorKovit Pattanapanyasaten_US
dc.contributor.authorCharin Thepthaien_US
dc.contributor.authorPornvaree Lamchiagdhaseen_US
dc.contributor.authorSurada Lerdwanaen_US
dc.contributor.authorKalaya Tachavanichen_US
dc.contributor.authorPrayoon Thanomsuken_US
dc.contributor.authorWanchai Wanachiwanawinen_US
dc.contributor.authorSuthat Fucharoenen_US
dc.contributor.authorJanice M. Dardenen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2018-09-07T09:08:44Z
dc.date.available2018-09-07T09:08:44Z
dc.date.issued2000-02-15en_US
dc.description.abstractInfection is very common in thalassemia and is one of the major causes of death. To date, it is not quite clear why these patients are susceptible to infection. In this study, lymphocyte immunophenotyping for CD3+ (T- cells), CD3+CD4+ (T-helper/inducer cells), CD3+CD8+ (T- suppressor/cytotoxic cells), CD3-CD19+ (B-cells), and CD3-CD16/56+ (natural killer cells) subsets and expression of the activation antigen CD69 on CD3+CD4+ and CD3+CD8+ T-cells were determined in the whole blood of thalassemia patients, using a three-color flow cytometric technique. Results showed that only splenectomized β-thalassemia/hemoglobin (Hb) E patients displayed a marked increase in absolute number of all lymphocytes. In addition, splenectomized β-thalassemia/Hb E showed a significantly lower percentage of CD3+ cells, with a corresponding increase in CD19+ cells. These differences, when compared with normal subjects and other thalassemia patients, may be attributed to splenectomy, α-thalassemia patients, on the other hand, showed no significant difference from the normal group. While lymphocyte subsets in splenectomized β-thalassemia/Hb E patients showed an abnormal distribution, T-cell activation in these patients was not different from the activation seen in normal subjects. This implies that thalassemia patients, during the steady state of disease, appear to have normal T- lymphocyte function with only moderate abnormalities of T- and B-lymphocyte subsets. (C) 2000 Wiley-Liss, Inc.en_US
dc.identifier.citationCommunications in Clinical Cytometry. Vol.42, No.1 (2000), 11-17en_US
dc.identifier.doi10.1002/(SICI)1097-0320(20000215)42:1<11::AID-CYTO3>3.0.CO;2-1en_US
dc.identifier.issn01964763en_US
dc.identifier.other2-s2.0-0034652575en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/25879
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034652575&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleLymphocyte subsets and specific T-cell immune response in thalassemiaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034652575&origin=inwarden_US

Files

Collections